Antonio Liras

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Effect of a truncated mutant factor V on hemostatic function and embryonic development in mice.

Effect of a truncated mutant factor V on hemostatic function and embryonic development in mice.

Journal: Scientific reports

Published: September 09, 2025

Development of a novel and viable knock-in factor V deficiency murine model: Utility for an ultra-rare disease.

Development of a novel and viable knock-in factor V deficiency murine model: Utility for an ultra-rare disease.

Journal: PloS one

Published: November 11, 2024

Treatment of congenital coagulopathies, from biologic to biotechnological drugs: The relevance of gene editing (CRISPR/Cas).

Treatment of congenital coagulopathies, from biologic to biotechnological drugs: The relevance of gene editing (CRISPR/Cas).

Journal: Thrombosis research

Published: July 17, 2023

The Magic of Proteases: From a Procoagulant and Anticoagulant Factor V to an Equitable Treatment of Its Inherited Deficiency.

The Magic of Proteases: From a Procoagulant and Anticoagulant Factor V to an Equitable Treatment of Its Inherited Deficiency.

Journal: International journal of molecular sciences

Published: February 24, 2023

Therapeutic potential of fetal liver cell transplantation in hemophilia A mice.

Therapeutic potential of fetal liver cell transplantation in hemophilia A mice.

Journal: Haematologica

Published: August 31, 2022

The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V.

The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V.

Journal: International journal of molecular sciences

Published: June 30, 2022

Development and Characterization of a Factor V-Deficient CRISPR Cell Model for the Correction of Mutations.

Development and Characterization of a Factor V-Deficient CRISPR Cell Model for the Correction of Mutations.

Journal: International journal of molecular sciences

Published: April 28, 2022

Standardization of Coagulation Factor V Reference Intervals, Prothrombin Time, and Activated Partial Thromboplastin Time in Mice for Use in Factor V Deficiency Pathological Models.

Standardization of Coagulation Factor V Reference Intervals, Prothrombin Time, and Activated Partial Thromboplastin Time in Mice for Use in Factor V Deficiency Pathological Models.

Journal: Frontiers in veterinary science

Published: December 30, 2021

High Mutational Heterogeneity, and New Mutations in the Human Coagulation Factor V Gene. Future Perspectives for Factor V Deficiency Using Recombinant and Advanced Therapies.

High Mutational Heterogeneity, and New Mutations in the Human Coagulation Factor V Gene. Future Perspectives for Factor V Deficiency Using Recombinant and Advanced Therapies.

Journal: International journal of molecular sciences

Published: August 04, 2021

Gene Therapy in Hemophilia: Recent Advances.

Gene Therapy in Hemophilia: Recent Advances.

Journal: International journal of molecular sciences

Published: June 30, 2021

Cell therapy for factor V deficiency: An approach based on human decidua mesenchymal stem cells.

Cell therapy for factor V deficiency: An approach based on human decidua mesenchymal stem cells.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: March 04, 2021

Dental management of patients with haemophilia in the era of recombinant treatments: increased efficacy and decreased clinical risk.

Dental management of patients with haemophilia in the era of recombinant treatments: increased efficacy and decreased clinical risk.

Journal: BMJ case reports

Published: April 10, 2019

Showing 1-12 of 28

Last Updated: 09/26/2026